Stored iron and vascular reactivity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 8, 2005, Pages 1532-1535

  Sullivan, Jerome L ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Endothelium; Genetics of cardiovascular disease; Iron; Myeloperoxidase; Oxidant stress

Indexed keywords

APOTRANSFERRIN; CELL ADHESION MOLECULE; FERRITIN; HEMOGLOBIN; MYELOPEROXIDASE; TRANSFERRIN;

BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; DISEASE SEVERITY; EDITORIAL; ENDOTHELIUM CELL; ENZYME ACTIVITY; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; IRON BINDING CAPACITY; IRON DEFICIENCY; IRON METABOLISM; IRON STORAGE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; IRON; MYOCARDIAL ISCHEMIA; RISK FACTORS; VASODILATION;

EID: 23244449501     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000174124.20147.22     Document Type: Editorial

References (60)

1. Zheng H, Cable R, Spencer B, Votto N, Katz SD. Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol. 2005;25:1577-1583.
2. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981;1:1293-1294.
3. Sullivan JL. The iron paradigm of isehemic heart disease. Am Heart J. 1989;117:1177-1188.
4. Sullivan JL. Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis. Am Heart J. 2003;145:190-194.
5. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003;349:1595-1604.
6. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, Hamm CW. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108:1440-1445.
7. Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J. 2001;142:336-339.
8. Zheng L, Settle M, Brubaker G, Schmitt D, Hazen SL, Smith JD, Kinter M. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. J Biol Chem. 2005;280:38-47.
9. Kartikasari AE, Georgiou NA, Visseren FL, Kats-Renaud H, van Asbeck BS, Marx JJ. Intracellular labile iron modulates adhesion of human monocytes to human endothelial cells. Arterioscler Thromb Vasc Biol. 2004;24:2257-2262.
10. Ober MD, Hart CM. Attenuation of oxidant-mediated endothelial cell injury with docosahexaenoic acid: the role of intracellular iron. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1998;59:127-135.
11. Varani J, Dame MK, Gibbs DF, Taylor CG, Weinberg JM, Shayevitz J, Ward PA. Human umbilical vein endothelial cell killing by activated neutrophils. Loss of sensitivity to injury is accompanied by decreased iron content during in vitro culture and is restored with exogenous iron. Lab Invest. 1992;66:708-714.
12. Ryter SW, Si M, Lai CC, Su CY. Regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron. Am J Physiol Heart Circ Physiol. 2000;279:H2889-H2897.
13. Sasaki K, Hashida K, Michigami Y, Bannai S, Makino N. Restored vulnerability of cultured endothelial cells to high glucose by iron replenishment. Biochem Biophys Res Commun. 2001;289:664-669.
14. Visseren FL, Verkerk MS, van Der BT, Marx JJ, van Asbeck BS, Diepersloot RJ Iron ehelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest. 2002;32(Suppl 1):84-90.
15. Satoh T, Tokunaga O. Intracellular oxidative modification of low density lipoprotein by endothelial cells. Virchows Arch. 2002;440:410-417.
16. Zhang WJ, Frei B. Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells. Free Radic Biol Med. 2003;34:674-682.
17. Koo SW, Casper KA, Otto KB, Gira AK, Swerlick RA. Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells. J Invest Dermatol. 2003;120:871-879.
18. Ramachandran A, Ceaser E, Darley-Usmar VM. Chronic exposure to nitric oxide alters the free iron pool in endothelial cells: role of mitochondrial respiratory complexes and heat shock proteins. Proc Natl Acad Sci U S A. 2004;101:384-389.
19. Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, Bach FH. Heme Oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol. 2004;172:3553-3563.
20. Dhanasekaran A, Kotamraju S, Kalivendi SV, Matsunaga T, Shang T, Keszler A, Joseph J, Kalyanaraman B. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem. 2004;279:37575-37587.
21. Sullivan J. Is stored iron safe? J Lab Clin Med. 2004;144:280-284.
22. Sullivan JL, Till GO, Ward PA. Iron depletion decreases lung injury after systemic complement activation. Fed Proc. 1986;45:452.
23. Sullivan JL, Till GO, Ward PA, Newton RB. Nutritional iron restriction diminishes acute complement-dependent lung injury. Nutrition Research. 1989;9:625-634.
24. Andrews FJ, Morris CJ, Lewis EJ, Blake DR. Effect of nutritional iron deficiency on acute and chronic inflammation. Ann Rheum Dis. 1987;46:859-865.
25. Chandler DB, Barton JC, Briggs DD III, Butler TW, Kennedy JI, Grizzle WE, Fulmer JD. Effect of iron deficiency on bleomycin-induced lung fibrosis in the hamster. Am Rev Respir Dis. 1988;137:85-89.
26. Patt A, Horesh IR, Berger EM, Harken AH, Repine JE. Iron depletion or ehelation reduces ischemia/reperfusion-induced edema in gerbil brains. J Pediatr Surg. 1990;25:224-227.
27. Salonen JT, Korpela H, Nyyssonen K, Porkkala E, Tuomainen TP, Belcher JD, Jacobs DR, Jr., Salonen R. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med. 1995;237:161-168.
28. Lee TS, Shiao MS, Pan CC, Chau LY. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation. 1999;99:1222-1229.
29. Lee HT, Chiu LL, Lee TS, Tsai HL, Chau LY. Dietary iron restriction increases plaque stability in apolipoprotein-e-deficient mice. J Biomed Sci. 2003;10:510-517.
30. van Jaarsveld H, Pool GF. Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein. Atherosclerosis. 2002;161:395-402.
31. Yoshiji H, Nakae D, Mizumoto Y, Horiguchi K, Tamura K, Denda A, Tsujii T, Konishi Y. Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient L-amino acid defined diet. Carcinogenesis. 1992;13:1227-1233.
32. Hayashi H, Takikawa T, Nishimura N, Yano M. Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C. J Hepatol. 1995;22:268-271.
33. Ponraj D, Makjanic J, Thong PS, Tan BK, Watt F. The onset of atherosclerotic lesion formation in hypercholesterolemic rabbits is delayed by iron depletion. FEBS Lett. 1999;459:218-222.
34. Facchini FS. Near-iron deficiency-induced remission of gouty arthritis. Rheumatology (Oxford). 2003;42:1-6.
35. Facchini FS, Saylor KL. Effect of iron depletion on cardiovascular risk factors: studies in carbohydrate-intolerant patients. Ann N Y Acad Sci. 2002;967:342-351.
36. Facchini FS, Saylor KL. A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy. Diabetes. 2003;52:1204-1209.
37. DePalma RG, Hayes VW, Cafferata HT, Mohammadpour HA, Chow BK, Zacharski LR, Hall MR. Cytokine signatures in atherosclerotic claudicants. J Surg Res. 2003;111:215-221.
38. Park YY, Hybertson BM, Wright RM, Repine JE. Serum ferritin increases in hemorrhaged rats that develop acute lung injury: effect of an iron-deficient diet. Inflammation. 2003;27:257-263.
39. Shoham S, Youdim MBH. Nutritional iron deprivation attenuates kainate-induced neurotoxicity in rats: implications for involvement of iron in neurodegeneratron. Ann N Y Acad Sci. 2004;1012:94-114.
40. Barollo M, D'Inca R, Scarpa M, Medici V, Cardin R, Fries W, Angriman I, Sturniolo GC. Effects of iron deprivation or chelation on DNA damage in experimental colitis. Int J Colorectal Dis. 2004;19:461-466.
41. Sullivan JL. Iron, plasma antioxidants, and the oxygen radical disease of prematurity. Am J Dis Child. 1988;142:1341-1344.
42. Gaenzer H, Marschang P, Sturm W, Neumayr G, Vogel W, Patsch J, Weiss G. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll of Cardiol. 2002;40:2189-2194.
43. Hurst JK. Whence nitrotyrosine? J Clin Invest. 2002;109:1287-1289.
44. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, Hazen SL. A tale of two controversies: i) Defining the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase deficient mice; and ii) Defining the nature of peroxidase-generated reactive nitrogen species. J Biol Chem. 2002;277:17415-17427.
45. Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P, Ma W, Tousson A, White CR, Bullard DC, Brennar ML, Lusis AJ, Moore KP, Freeman BA. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest. 2001;108:1759-1770.
46. Murakawa H, Bland CE, Willis WT, Dallman PR. Iron deficiency and neutrophil function: different rates of correction of the depressions in oxidative burst and myeloperoxidase activity after iron treatment. Blood. 1987;69:1464-1468.
47. Uritski R, Barshack I, Bilkis I, Ghebremeskel K, Reifen R. Dietary iron affects inflammatory status in a rat model of colitis. J Nutr. 2004;134:2251-2255.
48. Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, Shaposhnik Z, Funk CD, Lusis AJ, Shih W. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res. 2002;91:120-126.
49. Zhang YY, Lind B, Radmark O, Samuelsson B. Iron content of human 5-lipoxygenase, effects of mutations regarding conserved histidine residues. J Biol Chem. 1993;268:2535-2541.
50. Vita JA, Brennan ML, Gokce N, Mann SA, Goormastic M, Shishehbor MH, Penn MS, Keaney JF Jr, Hazen SL. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation. 2004;110:1134-1139.
51. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr, Vita JA. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 2001;103:2799-2804.
52. Zheng H, Dimayuga C, Hudaihed A, Katz SD. Effect of dexrazoxane on homocysteine-induced endothelial dysfunction in normal subjects. Arterioscler Thromb Vasc Biol. 2002;22:e15-e18.
53. Sullivan JL. Misconceptions in the debate on the iron hypothesis. J Nutr Biochem. 2001;12:33-37.
54. Kiechl S, Willeit J. Ongoing controversies surrounding the vascular benefits of blood donation. Circulation. 2001;104:E99.
55. Salonen JT, Tuomainen TP, Salonen R, Lakka TA, Nyyssonen K. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Epidemiol. 1998;148:445-451.
56. Meyers DG, Strickland D, Maloley PA, Seburg JK, Wilson JE, McManus BF. Possible association of a reduction in cardiovascular events with blood donation. Heart. 1997;78:188-193.
57. Meyers DG, Jensen KC, Menitove JE. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac-events. Transfusion. 2002;42:1135-1139.
58. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation. 2001;103:52-57.
59. Ahlers BA, Parnell MM, Chin-Dusting JP, Kaye DM. An age-related decline in endothelial function is not associated with alterations in L-arginine transport in humans. J Hypertens. 2004;22:321-327.
60. Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation. 1998;97:1234-1238.